New Hope for Tough-to-Treat Myeloma

Big news for multiple myeloma warriors: the EU just gave a thumbs up to linvoseltamab (aka Lynozyfic) for adults who’ve already tried at least three other treatments. In a recent trial, nearly half of patients on the higher dose saw a complete response! While side effects were common, this could be a game-changer for those running out of options. Fingers crossed for FDA approval in the US this summer! #MultipleMyeloma #CancerResearch #NewTreatment #HealthNews #Health